baber/WOPTO huggingface dataset:
Patent PT-1828519-E (PT)
Title: Door closer
Inventor: BIENEK VOLKER
IPC: E05F3/10
Filed: 2005-11-11
Abstract: A door closer includes a housing; an output shaft supported by the housing and rotatable in opposite door opening and closing directions; a cam disc disposed in the housing and mounted on the output shaft; a damping piston disposed in the housing; an opening piston disposed in the housing; first and second force transmission rollers; and two fixing bolts extending in the axial direction of the housing and transversely to the axis of the output shaft. The fixing bolts being disposed on two opposite sides of the output shaft, respectively. Each of the can disc and the first and second force transmission rollers has a circumferential recess or comprises two pieces, the fixing bolts being disposed in the recesses or between the respective two pieces so that each of the damping piston and the opening piston is prevented from rotating with respect to the cam disc.
Patent PT-2027063-E (PT)
Title: Method for producing chlorine by gas phase oxidation
Inventor: SCHUBERT STEPHAN
IPC: B01J23/46
Filed: 2007-05-16
Abstract: The present invention provides a process for producing chlorine by the catalytic gas phase oxidation of hydrogen chloride with oxygen, wherein the reaction is performed on at least two catalyst beds under adiabatic conditions, as well as a reactor system for performing the process.
Patent PT-2221666-E (PT)
Title: Positive-type photosensitive resin composition, method for production of resist pattern, and semiconductor device
Inventor: MATSUTANI HIROSHI
IPC: G03F7/23
Filed: 2008-11-07
Abstract: A positive-type photosensitive resin composition includes (A) a phenol resin modified by a compound having an unsaturated hydrocarbon group having 4 to 100 carbon atoms; (B) a compound that produces an acid by light; (C) a thermal crosslinking agent; and (D) a solvent. The positive-type photosensitive resin composition according to the present invention can be developed by an alkaline aqueous solution, and an effect thereof is that a resist pattern having sufficiently high sensitivity and resolution, excellent adhesion, and good thermal shock resistance can be formed.
Patent PT-2349427-E (PT)
Title: Larynx mask having an esophageal passage
Inventor: DUBACH WERNER F
IPC: A61M16/04
Filed: 2009-11-20
Abstract: A larynx mask comprises a cover plate having a peripheral cuff adjoining thereon and is provided with a tube insertion connector at the distal end, while the tip has a special design at the proximal end. The cover plate ends in the region of the tip on the cuff, or even before that, and the esophageal passage runs as an open channel over a constricted region of the cuff. Said channel preferably comprises a widening and is delimited on both sides by reinforcement means, which are preferably formed by reinforcing walls or additionally as reinforcing ribs. Said design of the lead-through of the esophageal passage results in a considerable reinforcement of the proximal tip of the larynx mask and therefore counteracts possible kinking of the tip.
Patent PT-2277865-E (PT)
Title: Phenyl-substituted 6-ring nitrogen-heterocycles as microtubule polymerisation inhibitors
IPC: C07D403/12
Filed: 2004-12-03
Abstract: Compounds of general formula (I), (II) (III) and (V) are described      
or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof, for use in modulating microtubule polymerisation in a subject.
Patent PT-618817-E (PT)
Inventor: CALLEGARO LANFRANCO
IPC: A61L15/28
Filed: 1992-12-18
Abstract: Biomaterials are disclosed comprised of biodegradable, biocompatible, and bioabsorbable nonwoven fabric materials for use in surgery for the guided regeneration of tissues. The non-woven fabric materials are comprised of threads embedded in a matrix, wherein both the matrix and the threads can be comprised of esters of hyaluronic acid, used singly or in combination, or esters of hyaluronic acid in combination with esters of alginic acid or other polymers.
Patent PT-760005-E (PT)
Inventor: EMBDEN JOHANNES DIRK ANTHONIE
IPC: C12Q1/689
Filed: 1994-05-16
Abstract: PCT No. PCT/NL94/00110 Sec. 371 Date Jan. 22, 1997 Sec. 102(e) Date Jan. 22, 1997 PCT Filed May 16, 1994 PCT Pub. No. WO95/31569 PCT Pub. Date Nov. 23, 1995A method and primary pair and kit for the in vitro amplification of nucleic acid using amplification primers in amplification reactions. There is used a pair of primers comprising oligonucleotide sequences complementary to a part of a Direct Repeat sequence of a microorganism belonging to the M tuberculosis complex of microorganisms, whereby hybridization to a Direct Repeat occurs and subsequently elongation of the hybridized primer takes place. The primers are such that elongation in the amplification reaction occurs for one primer in a 5' direction and for the other primer in a 3' direction.
Patent PT-793451-E (PT)
Inventor: PEPPER JOHN R
IPC: A61B17/17
Filed: 1995-10-25
Abstract: An intramedullary femoral rod provides a hollow rod body with five openings including a first group of three openings and a second group of two openings spaced at 180 DEG  from the first opening. The five openings define three passageways including two upwardly oblique passageways for femoral repairs or one downwardly oblique passageway for recon repairs.
Patent PT-831769-E (PT)
Inventor: LAVIN THOMAS N
IPC: A61K8/14
Filed: 1996-06-07
Abstract: A skin treatment composition for topical application comprises: at least one thyroid hormone compound or thyroid hormone-like compound, wherein said thyroid hormone compound or thyroid hormone-like compound is a chemical entity which binds to TR alpha  or TR beta  with a dissociation constant, Kd, lower than 1 mu M, wherein <DF>Kd = ÄRÜ • ÄLÜ / ÄRLÜ, </DF> wherein ÄRÜ is the concentration of receptor, ÄLÜ is the concentration of ligand and ÄRLÜ is the concentration of the receptor-ligand complex; at least one ingredient selected from vitamin D, glucocorticoids, retinoids and retinoic acid receptor binding compounds, or analogues thereof; and a pharmacologically acceptable base.
Patent PT-852684-E (PT)
Inventor: ROCHE EMILE
IPC: F17D1/20
Filed: 1996-09-23
Abstract: A hydropneumatic anti-hammer tank with an air intake device (1) in a water pipe in which pressure drops occur. The device includes a means for sensing the liquid pressure in a first pipe portion, and a means for opening a port (3a) leading to a second pipe portion. The means for sensing the liquid pressure in the first pipe portion may include a sealed chamber (4) with a variable volume communicating with said first pipe portion.
Patent PT-874862-E (PT)
Inventor: LIU JIH-HUA
IPC: C07H17/08
Filed: 1996-10-25
Abstract: A procedure for preparing 6-O-alkyl erythromycin compounds having the formula: wherein R<SUP>1 </SUP>is a loweralkyl group, R<SUP>2 </SUP>and R<SUP>3 </SUP>an independently hydrogen or a hydroxy-protecting group, except that R<SUP>2 </SUP>and R<SUP>3 </SUP>may not both be hydrogen simultaneously; Y is oxygen or a specifically substituted oxime; and Z is hydrogen, hydroxy or protected-hydroxy; by reaction of the compound wherein R<SUP>1 </SUP>is hydrogen with an alkylating reagent, is the presence of a strong alkali metal base and also in the presence of a weak organic amino base, in a suitable stirred or agitated polar aprotic solvent, or a mixture of such polar aprotic solvents maintained at a reaction temperature and for a period of time sufficient to effect alkylation.
Patent PT-912216-E (PT)
Inventor: WIRTH KARL-ERNST
IPC: B01D9/00
Filed: 1997-07-16
Abstract: An installation for purifying particulate solids, especially a salt purification facility, comprises a vertically standing purification vessel (1) which has on top a fill aperture (10) for the solids to be purified, below an outlet aperture (11) for the purified solids and at least one conical region (12, 13). At least one feed line (30, 31) into the purification vessel (1) and at least one downwardly directed and downwardly widening nozzle (33) are provided to feed in a purification brine in counterflow to the flow direction of the solids to be purified. The at least one conical region (12, 13) of the purification vessel (1) has an angle of conical opening of 10 DEG  to 30 DEG . This prevents clumping or channeling within the purification vessel, thus enhancing efficiency and prolonging uninterrupted service life without impairing the action of any downstream processing apparatus such as centrifuges.
Patent PT-936682-E (PT)
Inventor: SHIMIZU YOSHINORI
IPC: H05B33/00
Filed: 1997-07-29
Abstract: A light emitting device comprising: a light emitting component having a gallium nitride compound semiconductor element which has a light emitting layer being capable of emitting blue light, and a garnet phosphor activated with cerium excited by the blue light from said light emitting component and emit yellow light, wherein said light emitting device emit light by blending blue light emitted by the light emitting component and yellow light emitted by the phosphor.
Patent PT-937190-E (PT)
Inventor: MOFFAT WILLIAM
IPC: E06C7/12
Filed: 1997-10-22
Abstract: A mobile ladder (10) including a goods lift (12) which can be driven between upper (FIG. 3) and lower (FIG. 4) positions. The ladder has a default-immobile state which can be overcome by a force manually applied to a handle. The ladder can then be moved and steered via the handle.
Patent PT-1001806-E (PT)
Inventor: LAURENCE ZITVOGEL
IPC: A61K35/12
Filed: 1998-07-03
Abstract: Vesicle (A, designated texosome) derived from tumour cells (a) is separated from its natural environment and comprises a lipid bilayer surrounding a cytosolic fraction (CF) or (b) has diameter 60-90 nm and presents at its surface: (i) tumour-specific antigenic peptides associated with MHC (major histocompatibility complex) Class I and/or II molecules; and (ii) molecules (I) for co-stimulation of lymphocytes. Also new are: (1) antigen-presenting cells (APC) loaded with (A); (2) membrane vesicles (B) separated from their natural environment, secreted by the APC of (1); (3) membrane vesicles (C, designated dexosomes) derived from a dendritic cell (DC) and containing at least one each of MHC Class I and Class II molecules; (4) combination of texosomes and/or dexosomes with an immunostimulating adjuvant for use simultaneously, separately or staged in time; and (5) use of interleukin (IL)-10 and/or IL-12 for production of dexosomes.
Patent PT-1084168-E (PT)
Inventor: KUHLMANN PETER
IPC: C08G18/42
Filed: 1999-05-19
Abstract: A two-component water paint system that allows reliable formation of essentially bubble-free paint films having a thickness of at least 120 mum. The water paint system comprises an aqueous emulsion of a hydroxy-functional alkyd resin wherein the hydroxy-functional alkyd resin can be obtained from an oleic or fatty acid component, a polyvalent alcohol, a polyether polyol having a molecular weight of 400 to 8,000, a monobasic carboxylic acid and a polycarboxylic acid or the anhydride thereof.
Patent PT-1124432-E (PT)
Inventor: JEAN-YVES BARBEAU
IPC: A23C13/12
Filed: 1999-11-02
Abstract: The invention concerns dairy product capsules and the method for making them. The capsules contain a coating including a food polymer, reactive to multivalent ions, inside which is confined a dairy product. The capsules are characterised in that they have a breaking force higher than 0.5 N. The invention is applicable in the food processing industry.
Patent PT-1124539-E (PT)
Inventor: BERGSTRAND PONTUS
IPC: A61K31/4439
Filed: 1999-11-03
Abstract: An enteric coated oral pharmaceutical formulation comprising as active ingredient a compound selected from the group of omeprazole, an alkaline salt of omeprazole, one of the single enantiomers of omeprazole and an alkaline salt of one of the single enantiomers of omeprazole, wherein the formulation comprises a core material that comprises the active ingredient and optionally an alkaline reacting compound, the active ingredient is in admixture with a pharmaceutically acceptable excipient, such as for instance a binding agent, and on said core material a separating layer and an enteric coating layer. A hydroxypropyl cellulose (HPC) with a specific cloud point is used in the manufacture of the claimed pharmaceutical formulations. Furthermore, the application describes the processes for their preparation and the use of the claimed formulations in medicine.
Patent SG-131992-G (SG)
Title: Timer
IPC: G04C3/00
Filed: 1992-12-26
Abstract: A timer advantageously in the form of a wristwatch and is combined with the time indicating function of the watch. The timer comprises a setting device enabling an accumulator to be loaded through the medium of a position transducer. The movement of the setting device being a stepwise one, each of its shifts enables a pulse to be generating which corresponds to a number of reference periods supplied by a time base. The accumulator is counted down by the time base and, when the accumulator is empty, a warning signal generating device is triggered.
Patent IE-37252-L (IE)
Title: 6, 6-disubstituted penicillins and 7, 7-disubstituted¹cephalosporins
IPC: C07D499/46
Filed: 1973-01-26
Abstract: 6-Alkoxylated-6-acylamidopenicillanic acids and 7-alkoxylated-7-acylamidocephalosporin acids and esters thereof, are provided by reacting a 6-acylamidopenicillanic acid ester or a 7-acylamidocephalosporin ester under anhydrous conditions at -90 DEG C. to -15 DEG C. with an alkali metal salt of a lower alkyl alcohol in the presence of an excess of the corresponding alcohol to produce, in situ, the anionic form of the antibiotic which on halogenation with a positive halogen compound, e.g. t-butyl hypochlorite, yields the compound of the invention. Compounds of the invention, e.g. 6-methoxy-6-phenoxyacetamidopenicillanic acid and 7-methoxy-7-[2-(2-thienyl)acetamido]cephalosporanic acid are useful antibiotics.
[US3994885A]
Patent IE-890269-L (IE)
Title: Composition of anticoagulants
IPC: A61K38/55
Filed: 1989-01-27
Abstract: An anticoagulant containing as active ingredients protein C or activated protein C and heparin has a high anticoagulant activity which cannot be obtained with activated protein C or heparin alone. The activity of the anticoagulant is further increased by addition of AT III.
Patent IE-39084-L (IE)
Title: Dispensers for tissue paper or the like
IPC: B65D25/52
Filed: 1974-03-20
Abstract: A dispenser for a treated perforated tissue web wherein said dispenser is provided with an opening for extraction of the web from the dispenser, said opening having associated therewith an interior flap which normally all but closes the opening through which the web is withdrawn thereby providing sufficient tension on the web to cause it to tear off at the perforations. A variation includes a form in which the flap is such that it completely closes and overlaps the opening in the dispenser forcing the web to travel in a tortuous path.[US3843017A]
Patent IE-830863-L (IE)
Title: Pressure swing adsorption system
IPC: C01B21/04
Filed: 1983-04-15
Abstract: Gas mixtures are separated on a two column molecular sieve pressure swing adsorption (PSA) system to produce an enriched gas stream. This process features the use of a product gas purge, an inlet vent gas and feed gas for the repressurization of a regenerated column and does not require vacuum or an air receiver.
[US4440548A]
Patent IE-820910-L (IE)
Title: Improving milk yield
IPC: A23K20/195
Filed: 1982-04-19
Abstract: Glycopeptide antibiotics improve milk production in lactating ruminants when administered orally to the ruminants in a propionate-increasing amount.
Patent IE-850939-L (IE)
Title: Oxazine dopamine agonists
IPC: C07D265/00
Filed: 1985-04-12
Abstract: Compounds are disclosed having the formula:  <IMAGE>  wherein: R1 is H, OH, -OCH3, -CH2OH, -NH2, -NHMe, -NHEt, -NMe2, -NEt2,  <IMAGE>  R2 is H, -CH3, or  <IMAGE>  R3 is phenyl, benzyl, or 1-4 carbon alkyl; R4 is H, -CH3, -CH2OH, -CH2-CN, -CH2-S-Me, CH2-S-CN, or  <IMAGE>  R5 is H, 1-4 carbon alkyl, alkenyl, or alkynyl, or aralkyl having a 1-4 carbon alkylene moiety; and A is -CH2-or -CH2CH2-, and pharmaceutically-acceptable salts thereof. Pharmaceutical preparations using these compounds and a method for inducing a dopaminergic response by administering these compounds are also disclosed.
Patent FI-812962-L (FI)
Inventor: SCHACHT BODO
IPC: A61M25/00
Filed: 1981-09-23
Abstract: 1. An introduction device for catheters, probes or the like, comprising a housing body (2) which has a continuous longitudinal channel (5) to be connected to a cannula (24), and comprising two sealing elements (10, 16) which are positioned in tandem on the rear end of the housing body (5), are each made of elastic material and have expandable openings (11, 18) for the passage of elongate objects (25, 26), characterised in that the first sealing element (10) consists of a part which is tubular in an idle condition, the front section of which freely projects axially into the channel (5) of the housing body (2) and has at its front two sealing lips (12, 13) which press against each other, and the second sealing element (16) consists of a disc which is positioned between the rear end of the housing body and he first sealing element (10) and has an expandable opening (18) which is produced without removing any material.
Patent FI-823282-L (FI)
Inventor: IDE JUNYA
IPC: C07C59/11
Filed: 1982-09-24
Abstract: Compounds of formula (I):   <IMAGE> (I)  [wherein X represents a hydrogen atom or a 2-methylbutyryl group, Y represents a hydrogen atom or a methyl group and R1 and R2 are the same or different and each represents an oxygen atom or a group of formula =N-OR3 (wherein R3 represents a hydrogen atom or an alkyl group)], the free hydroxy-carboxylic acids corresponding thereto and salts and esters of said acids may be prepared by oxidizing and, if necessary, oximating a corresponding ML-236A, ML-236B, MB-530A or MB-530B compound, and these compounds have valuable antihypercholesteraemic activity.
Patent FI-844415-L (FI)
Inventor: VON SEYERL JOACHIM
IPC: C08G59/40
Filed: 1984-11-09
Abstract: 1. Hardener for epoxide resin masses based on dicyandiamide, characterised in that it contains a) dicyandiamide with a grain size of >= 90% =< 10 mu m and b) 0.1 to 30 wt.% silicon dioxide and/or a metal oxide of the II main or subsidiary Group with a specific surface area according to BET of at least 50 m**2 /g.
Patent IE-37926-L (IE)
Title: Azabicyclic esters of omega-(4-biphenylyl) alkanoic acids.
IPC: C07D221/22
Filed: 1973-07-19
Abstract: 1382958 Esters of biphenylalkanoic acids with azabicycloalkanols G D SEARLE & CO 19 July 1973 [21 July 1972] 34578/73 Heading C2C Novel compounds of Formula I wherein Alk represents an alkylene radical containing 2 to 7 carbon atoms and Az represents the residue of an azabicycloalkanol containing 7 or 8 carbon atoms and a nitrogen atom in the ring structure, the ring structure optionally containing a keto group next to the nitrogen atom with the proviso that the nitrogen atom is substituted when no keto group is present and optionally substituted when the keto group is present are prepared by reacting the biphenyl alkanoic acid or a derivative thereof with the alcohol A 2 OH to form the ester. Biphenyl alkanoic acid chlorides are prepared by action of SOCl 2 on the acid. Azabicycloalkanols are prepared by LiAlH 4 reduction of the 3-keto-azabicycloalkanol. 2 - Ethyl - hexohydroxy - 2 - aza - bicyclo - [2,2,2]- octan-3-one is prepared from 3-carbomethoxy-7- oxabicyclo-[4,1,0]-heptane and ethylamine. Pharmaceutical compositions in conventional forms for oral or parenteral administration and having antiviral, antihypercholesterolemic and hypolipermic activity comprise an above novel compound and a carrier or diluent.
[GB1382958A]
Patent IE-39516-L (IE)
Title: Corticoid-containing inhalant preparations
IPC: A61K31/16
Filed: 1974-06-20
Abstract: 1479488 Inhalant compositions SCHERING AG 24 June 1974 [23 June 1973] 27902/74 Heading A5B Inhalant compositions suitable for treatment of allergic disorders of the respiratory tract comprise a corticoid of formula:- in which -B-A- represents -CH 2 -CH 2 -, -CH=CH-, or -CCl=CH-; X is H, F or CH 3 ; Y is H, F or Cl; Z is -CH 3 -, -C(OH)H-, -CFH-, -CClH-, or -C(O)-; R 1 is H or CH 3 ; R 2 is H, or R 1 and R 2 together are an isopropylidene-dioxy group: and R 3 is a C 1 -C 12 hydrocarbon residue, in admixture or conjunction with a suitable carrier. The compositions may be in a capsule and contain dextran, mannitol, glucose or lactose as carrier. Antibodies such as chloramphenicol tetracyclines, penicillins cephalosporins. lincomycins, erythromycins and rifamycins, may also be present.
[GB1479488A]
Patent IE-34772-L (IE)
Title: Display chart
IPC: G09F7/02
Filed: 1970-12-03
Abstract: 1299606 Indicator boards BEANSTALK SHELVING Ltd 3 Dec 1970 [8 Dec 1969] 59876/69 Heading G5C A chart device comprises a grid panel 1 made up of a number of elongate channel-shaped sections 2, between the side walls 2A of which bars 3 are fixed. The panel 1 is held by a frame 4 comprising trim strips 4A and corner mouldings 4B. The trim strips 4A have a C-sectioned portion 6 by which the assembly can be mounted on a wall. Indicator members 9 consisting of cards 9A and holders 9B are attached to the panel 1, each holder 9B having a base portion for gripping a card 9A, and spigots (or other protuberances) 13 for clipping the assembly over a rod 3. The arm portion 11 of the holder 9B has ribs 12 to assist manual manipulation of the member 9. A modification of the holder 9B (Fig. 6A, not shown) is formed from a sheet of resilient material, and a further modification (Fig. 6B, not shown) has a forklike configuration for gripping the cards, both modifications having spigots or the like, as before. In another embodiment, the panel 1 is replaced by a base member having ribs and spigots in place of the side walls 2A and rods 3 respectively. The chart can be used as in Fig. 1, or perpendicular to it with the rods 3 vertical.
[GB1299606A]
Patent IE-38329-L (IE)
Title: Thioxanthone derivatives
IPC: C07D335/16
Filed: 1973-09-06
Abstract: Thioxanthone derivatives of the formula I, wherein Z<1> denotes a carboxyl, 5-tetrazolyl, 5-(1-alkyl)tetrazolyl or 5-(2-alkyl)tetrazolyl group, with the alkyl groups having 1 to 6 carbon atoms and being optionally substituted by a hydroxyl group or a basic or acidic group and Z<2> denotes hydrogen, halogen, an amino or nitro group, an alkyl group having 1 to 6 carbon atoms, an alkoxy, alkylthio, acyl or acylamino group having 1 to 6 carbon atoms or a 5-tetrazolyl, 5-(1-alkyl)tetrazolyl or 5-(2-alkyl)tetrazolyl group, with the alkyl groups having 1 to 6 carbon atoms and being optionally substituted by a hydroxyl group or a basic or acidic group, are active compounds and are obtained if appropriately substituted diphenyl sulphide derivatives, which in the 2-position possess a carboxyl group or a reactive functional derivative of such a group, are cyclised in the presence of Lewis acids or of protonic acids. The compounds are optionally converted to their salts or, if at least one of the substituents is a carboxyl group, to their esters or amides by esterification or amidation. The compounds act as inhibitors of certain allergic reactions in mammals. Several of the compounds of the formula I which have been prepared are novel. <IMAGE>
[GB1458185A]